Actinomyces induces activation of the TLR2/NF-κB and TLR4/NF-κB pathways to promote inflammation and suppress anti-tumor responses by inhibiting the infiltration of CD8+ T lymphocytes (Figure 7). The gene discussed is NFKB1; the disease is neoplasm.